Hill S, Khullar V, Wyndaele JJ, Lheritier K ; Darifenacin Study Group.
Dose response with darifenacin, a novel once-daily M3 selective receptor antagonist for the treatment of overactive bladder: results of a fixed dose study.
Int Urogynecol J Pelvic Floor Dysfunct 2006;
17 (3) 239-247
Download Bibliographical Data